Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 3:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Parkinson's Disease, Erectile Dysfunction
Interventions: Selegiline, Tadalafil; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 40 Years to 64 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Erectile Dysfunction
Interventions: MED3000 (Male), Tadalafil 5mg (Male), MED3000 (Female), Tadalafil 5mg (Female); Device · Drug
Lead sponsor: Futura Medical Developments Ltd.; Industry
Eligibility: 22 Years to 70 Years · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sedative Abuse
Interventions: sodium oxybate, triazolam and pentobarbital; Drug
Lead sponsor: Orphan Medical; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Fecal Incontinence
Interventions: No intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sleep Deprivation
Interventions: sleep restriction; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 40 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Treatment Outcome
Interventions: Vortioxetine, Escitalopram, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 53
States / cities: Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 50 more

Conditions: Suicide, Depressive Disorder, Treatment-Resistant, Ketamine, Molecular Mechanisms of Pharmacological Action, Neurotransmitter Agents, Excitatory Amino Acid Agents, Physiological Effects of Drugs, Depressive Disorder, Major, Depressive Disorder, Depression, Mental Disorders, Mood Disorders, Behavioral Symptoms
Interventions: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg), Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Endometriosis
Interventions: Relugolix, Estradiol/norethindrone acetate; Drug
Lead sponsor: Myovant Sciences GmbH; Industry
Eligibility: 18 Years to 51 Years · Female only
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 60
States / cities: Andalusia, Alabama • Scottsdale, Arizona • Tucson, Arizona + 50 more

Conditions: Alcohol Use, Unspecified, Sexual Dysfunction, Sexual Assault
Interventions: AWARE; Behavioral
Lead sponsor: Lifespan; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Sexual Dysfunction, Pelvic Floor Disorders, Gynecologic Cancer
Interventions: Integrated Physical Therapy and Coping Skills Training; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Spinal Muscular Atrophy
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 5 Years to 20 Years
Enrollment: 24 participants
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Hypogonadism, Erectile Dysfunction
Interventions: Testim®, Placebo Testim®, Viagra®; Drug · Other
Lead sponsor: Mohit Khera; Other
Eligibility: 18 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Aging
Interventions: MitoQ, Placebo; Drug
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 60 Years to 79 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Bradycardia, Sinus Node Dysfunction, Heart Block, Syncope, Cardiomyopathies, Ventricular Tachycardia, Heart Failure
Interventions: Physiologic pacing device implant; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 870 participants
Timeline: 2018 – 2021
U.S. locations: 26
States / cities: Huntsville, Alabama • Burlingame, California • San Diego, California + 22 more

Conditions: Breast Cancer, Gynecologic Cancer, Sexual Dysfunction, Partner Communication
Interventions: Self-Guided PEPP Intervention Workbook, Self-Guided PEPP Education Workbook; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Ejaculatory Dysfunction, Premature Ejaculation, Delayed Ejaculation, Anorgasmia, Anejaculation, Dysejaculation, Dysorgasmia
Interventions: Not listed
Lead sponsor: Charitable Union for the Research and Education of Peyronie's Disease; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Orem, Utah

Conditions: Breast Cancer, Vaginal Dryness
Interventions: pilocarpine hydrochloride, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Female only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 192
States / cities: Aurora, Colorado • Boulder, Colorado • Colorado Springs, Colorado + 123 more

Conditions: Longitudinal Studies, Prospective Studies, Biomarkers, Predictive Value of Tests, Telemedicine, Time of Death, Time Perception, Time Reaction, Time Efficiency, Time Management, Population, Population Groups, Epidemic Disease, Pandemic, Sex Behavior, Sex Characteristics, Sex Hormone, Cardio-pulmonary, Surgical, Drugs of Abuse, Health Risks, Clinical Outcomes
Interventions: No Study-Assigned Intervention; Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2076
U.S. locations: 1
States / cities: New York, New York

Conditions: Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy, Menopause Syndrome, Dyspareunia
Interventions: Intrarosa, Placebos; Drug
Lead sponsor: Center for Vulvovaginal Disorders; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • New York, New York

Conditions: Achondroplasia
Interventions: BMN 111, Placebo; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 5 Years to 18 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 11
States / cities: Oakland, California • Torrance, California • Wilmington, Delaware + 8 more

Conditions: Mental Health Issue
Interventions: Meditation; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 8 Years to 12 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Brain Injuries, Traumatic
Interventions: ICP + PbtO2 guided management strategy, ICP guided management strategy; Other
Lead sponsor: University of Michigan; Other
Eligibility: 14 Years and older
Enrollment: 1,094 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 48
States / cities: Los Angeles, California • Palo Alto, California • Sacramento, California + 38 more

Conditions: Heat Intolerance, Heat Stress, Fatigue; Heat
Interventions: Antioxidant Berry Supplementation, Acute and Chronic Exercise-Heat Stress, Placebo (non-juice) Supplementation; Dietary Supplement · Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 50 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Storrs, Connecticut

Search by objective public record fields.

Sagene 2014 - Parkinson's Disease and Erectile Dysfunction

Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

Physiological, Behavioral and Subjective Effects of Drugs (GHB)

Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders

Physiologic Effects of Sleep Restriction

Physiological Effects of Androstadienone Exposure

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Improving Women's Function After Pelvic Radiation

Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies

Testosterone for Penile Rehabilitation After Radical Prostatectomy

The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults

Physiologic Pacing Registry

Psychosexual Educational Partners Program (PEPP)

Ejaculatory and Orgasmic Dysfunction Registry

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

Clinical Time and Temporal Dynamics Study (CLIN-TIME)

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

Community-Based Music Mindfulness Intervention on Children

Brain Oxygen Optimization in Severe TBI, Phase 3

Acquiring and Targeting Heat Exposures Necessary for Action